Literature DB >> 15490093

Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers.

Junming Guo1, Bingxiu Xiao, Xinjun Zhang, Zhijin Jin, Jian Chen, Lijun Qin, Xiongying Mao, Guangyu Shen, Hui Chen, Zhong Liu.   

Abstract

To establish a novel molecular diagnostic method of detecting circulating tumor cells (CTCs) LS174T colon cancer cells were serially diluted with normal blood. Additional peripheral blood samples were collected from 25 patients with colorectal carcinoma. Mononuclear cells (MNCs) were collected, equally divided into four parts, and then cancer cells were enriched by four methods: method A, nonimmunobead method; method B, negative immunobead method: CD45 immunomagnetic beads were used to deplete the leukocytes; method C, positive immunobead method: Ber-EP4 immunomagnetic beads were used to enrich cancer cells; method D, negative-and-positive immunobead method: CD45 immunomagnetic beads were first used to deplete the leukocytes from MNC and then Ber-EP4 immunomagnetic beads were used to enrich cancer cells. Finally, real-time quantitative RT-PCR was used to monitor mRNA expression of beta2-mircoglobulin (beta2M) and carcinoembryonic antigen (CEA). The relative CEA mRNA values were corrected with reference to beta2M mRNA, to CEA mRNA/beta2M mRNA ratios according to a CEA mRNA external standards prepared with tenfold serial dilutions (1-10(4) IS174T cells) of cDNA and beta2M mRNA external standards prepared with tenfold serial dilutions (10(2)-10(7) leukocytes) of cDNA. In recovery experiments a significant correlation between the number of cancer cells and CEA mRNA expression was found when CD45 or Ber-EP4 immunomagnetic beads were used alone. A highly significant correlation was found when CD45 and Ber-EP4 immunomagnetic beads were used successively. The sensitivity of method D was one cancer cell per milliliter of blood. Circulating cancer cells were detected in 19 of 25 patients with colorectal cancers. The relative CEA mRNA value obtained by method D was the smallest. The positive detection rate of circulating cancer cells in patients at Dukes' B, C, and D stages were 25.0% (1/4), 83.3% (10/12), and 88.9% (8/9). Combinative use of immunomagnetic isolation followed by real-time RT-PCR is a useful technique to detect circulating tumor cells in patients with colorectal carcinomas. Applying negative and positive immunomagnetic beads successively yields the highest correlation with amount of tumor cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15490093     DOI: 10.1007/s00109-004-0590-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  20 in total

1.  Circulating malignant cells and fibrinolysis during resection of colorectal cancer.

Authors:  H White; J D Griffiths
Journal:  Proc R Soc Med       Date:  1976-07

2.  Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction.

Authors:  J E Hardingham; D Kotasek; B Farmer; R N Butler; J X Mi; R E Sage; A Dobrovic
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

3.  Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma.

Authors:  K Sheibani; S S Shin; J Kezirian; L M Weiss
Journal:  Am J Surg Pathol       Date:  1991-08       Impact factor: 6.394

4.  Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.

Authors:  P de Cremoux; J M Extra; M G Denis; J Y Pierga; E Bourstyn; C Nos; K B Clough; E Boudou; E C Martin; A Müller; P Pouillart; H Magdelénat
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

5.  Normalizing complementary DNA by quantitative reverse transcriptase-polymerase chain reaction of beta2-microglobulin: molecular monitoring of minimal residual disease in acute promyelocytic leukemia.

Authors:  M Degan; F T Mazzocco; R Di Francia; F M Rossi; A Pinto; V Gattei
Journal:  Diagn Mol Pathol       Date:  2000-06

6.  Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

Authors:  P J Bostick; S Chatterjee; D D Chi; K T Huynh; A E Giuliano; R Cote; D S Hoon
Journal:  J Clin Oncol       Date:  1998-08       Impact factor: 44.544

Review 7.  Polymerase chain reaction in the detection of micrometastases and circulating tumor cells.

Authors:  R A Ghossein; J Rosai
Journal:  Cancer       Date:  1996-07-01       Impact factor: 6.860

8.  Quantitative detection of CEA expressing free tumor cells in the peripheral blood of colorectal cancer patients during surgery with real-time RT-PCR on a LightCycler.

Authors:  Seiji Ito; Hayao Nakanishi; Takashi Hirai; Tomoyuki Kato; Yasuhiro Kodera; Zhang Feng; Yasushi Kasai; Katsuki Ito; Seiji Akiyama; Akimasa Nakao; Masae Tatematsu
Journal:  Cancer Lett       Date:  2002-09-26       Impact factor: 8.679

9.  Optimisation of the RT-PCR detection of immunomagnetically enriched carcinoma cells.

Authors:  Michael Raynor; Sally-Anne Stephenson; David C A Walsh; Kenneth B Pittman; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2002-05-24       Impact factor: 4.430

10.  Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.

Authors:  S A Burchill; M F Bradbury; K Pittman; J Southgate; B Smith; P Selby
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

View more
  11 in total

1.  Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker.

Authors:  Hui Zhou; Jun-Ming Guo; Yan-Ru Lou; Xin-Jun Zhang; Fa-De Zhong; Zhen Jiang; Jia Cheng; Bing-Xiu Xiao
Journal:  J Mol Med (Berl)       Date:  2010-03-28       Impact factor: 4.599

2.  Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.

Authors:  Nadia Dandachi; Marija Balic; Stefanie Stanzer; Michael Halm; Margit Resel; Thomas Anton Hinterleitner; Hellmut Samonigg; Thomas Bauernhofer
Journal:  J Mol Diagn       Date:  2005-11       Impact factor: 5.568

3.  Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients.

Authors:  Aikaterini Tsouma; Chrysanthi Aggeli; Panagiotis Lembessis; George-N Zografos; Dimitris-P Korkolis; Dimitrios Pectasides; Maria Skondra; Nikolaos Pissimissis; Anastasia Tzonou; Michael Koutsilieris
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

4.  Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies.

Authors:  Dalibor Antolovic; Luis Galindo; Anina Carstens; Nuh Rahbari; Markus W Büchler; Jürgen Weitz; Moritz Koch
Journal:  BMC Biotechnol       Date:  2010-04-28       Impact factor: 2.563

5.  Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.

Authors:  Yan Ning; Diana L Hanna; Wu Zhang; Angela Mendez; Dongyun Yang; Rita El-Khoueiry; Satoshi Matsusaka; Yu Sunakawa; Stefan Stremitzer; Anish Parekh; Satoshi Okazaki; Martin D Berger; Afsaneh Barzi; Heinz-Josef Lenz
Journal:  Mol Cancer Ther       Date:  2015-07-30       Impact factor: 6.261

Review 6.  Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours.

Authors:  María José Serrano Fernádez; Juan Carlos Alvarez Merino; Iñigo Martínez Zubiaurre; Ana Fernández García; Pedro Sánchez Rovira; José Antonio Lorente Acosta
Journal:  Clin Transl Oncol       Date:  2009-10       Impact factor: 3.405

7.  Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer.

Authors:  Rossella Solmi; Giampaolo Ugolini; Giancarlo Rosati; Simone Zanotti; Mattia Lauriola; Isacco Montroni; Marco del Governatore; Antonello Caira; Mario Taffurelli; Donatella Santini; Domenico Coppola; Lia Guidotti; Paolo Carinci; Pierluigi Strippoli
Journal:  BMC Cancer       Date:  2006-10-20       Impact factor: 4.430

8.  Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review.

Authors:  Somayeh Vafaei; Fahimeh Fattahi; Marzieh Ebrahimi; Leila Janani; Ahmad Shariftabrizi; Zahra Madjd
Journal:  Cancer Manag Res       Date:  2019-09-25       Impact factor: 3.989

9.  Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification.

Authors:  M J Smith; A C Culhane; M Donovan; J C Coffey; B D Barry; M A Kelly; D G Higgins; J H Wang; W O Kirwan; T G Cotter; H P Redmond
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

10.  The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course.

Authors:  A Taddei; F Castiglione; M N Ringressi; E Niccolai; L Tofani; L Boni; P Bechi; A Amedei
Journal:  Mediators Inflamm       Date:  2015-10-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.